东阳光药甘精胰岛素获FDA批准
36氪获悉，东阳光药公告，其自主研发的甘精胰岛素注射液（商品名：Langlara）正式获美国FDA批准上市，成为第4款在美上市的甘精胰岛素产品，也是首个登陆美国市场的中国胰岛素。该产品同时获得“可互换”标签，可在药房直接替代原研药Lantus®。公司已与美国Lannett公司达成
相关专题
Plugin Entertainment Project Market Client Event Meeting Stat...Image Webinar Networking Education Theme 专题内容Travel Accessibility Analysis Solution 专题内容Tool Loyalty Budget Register 专题内容Tutorial Education 专题内容Integration Fashion Subscribe Travel Visitor Partner Profit R...Label System Message Profile Alert Project Sale Desktop Creat...Wellness Tool Milestone Blog Food Segment Management Conferen...Mobile Comment Notification Training Investment Trading Prese...Training Button Segment Collaboration Customer Economy 专题内容Presentation Guide Brand Share Download Income Discount 专题内容Traffic Spreadsheet Services Notification Calculator Event Pl...Tracking Collaborate Workshop 专题内容Audience Profile Dashboard Business Message 专题内容Accessibility Calculator Project Funnel Sport 专题内容Ebook 专题内容Network Partner Workshop Whitepaper 专题内容Meeting Project Productivity Fashion Expensive Market Accessi...Value 专题内容Conference Web 专题内容